These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8939401)

  • 1. Comparison of four digoxin immunoassays with respect to interference from digoxin-like immunoreactive factors.
    Datta P; Hinz V; Klee G
    Clin Biochem; 1996 Dec; 29(6):541-7. PubMed ID: 8939401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical performance of a monoclonal digoxin assay with increased specificity on the ACS:180.
    Miller JJ; Straub RW; Valdes R
    Ther Drug Monit; 1996 Feb; 18(1):65-72. PubMed ID: 8848824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antibody specificity on results of selected digoxin immunoassays among various clinical groups.
    Datta P; Xu L; Malik S; Landicho D; Ferreri L; Halverson K; Roby PV; Zebelman AM; Kenny MA
    Clin Chem; 1996 Mar; 42(3):373-9. PubMed ID: 8598098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference from digitoxin-like immunoreactive factors reduced in a new monoclonal chemiluminescent digitoxin assay.
    Datta P; Dasgupta A
    Ther Drug Monit; 1998 Dec; 20(6):663-8. PubMed ID: 9853984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New enzyme-linked immunosorbent digoxin assay on the ADVIA IMS 800i system is virtually free from interference of endogenous digoxin-like immunoreactive factors.
    Dasgupta A; Kang E; Datta P
    Ther Drug Monit; 2005 Apr; 27(2):139-43. PubMed ID: 15795642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors.
    Matheke ML; Valdes R
    Ann Clin Lab Sci; 1989; 19(3):168-74. PubMed ID: 2658726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference of endogenous digoxin-like immunoreactive factors in serum digoxin measurement is minimized in a new turbidimetric digoxin immunoassay on ADVIA 1650 analyzer.
    Datta P; Dasgupta A
    Ther Drug Monit; 2004 Feb; 26(1):85-9. PubMed ID: 14749555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new digoxin immunoassay substantially free of interference by digoxin immunoreactive factor.
    Jiang F; Wilhite TR; Smith CH; Landt M
    Ther Drug Monit; 1995 Apr; 17(2):184-8. PubMed ID: 7624908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter study of Abbott AxSYM Digoxin II assay and comparison with 6 methods for susceptibility to digoxin-like immunoreactive factors.
    Azzazy HM; Duh SH; Maturen A; Schaller E; Shaw L; Grimaldi R; Shock G; Christenson RH
    Clin Chem; 1997 Sep; 43(9):1635-40. PubMed ID: 9299945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of five immunoassays for the determination of digoxin in serum.
    Sasieta M; Jimeno P
    Eur J Clin Chem Clin Biochem; 1996 Nov; 34(11):935-40. PubMed ID: 8960471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous digoxin-like immunoreactive factors (DLIF) as measured by the CEDIA digoxin assay and a fluorescence polarization immunoassay.
    Schlebusch H; Jarausch J; Domke I
    Wien Klin Wochenschr Suppl; 1992; 191():59-66. PubMed ID: 1509757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin-like immunoreactive substance: monoclonal and polyclonal RIA and FPIA compared.
    Mojaverian P; Green PJ; Jhangiania RK; Chase GD
    J Pharm Biomed Anal; 1989; 7(5):585-92. PubMed ID: 2490762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved interassay correlation of digoxin results in patients with and without renal failure by elimination of digoxin-like immunoreactive factors.
    Skogen WF; Rea MR; Valdes R
    Clin Chem; 1987 Jun; 33(6):837-9. PubMed ID: 3594830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous digoxin-like immunoreactive factors: impact on digoxin measurements and potential physiological implications.
    Valdes R
    Clin Chem; 1985 Sep; 31(9):1525-32. PubMed ID: 3896570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous digoxin-like immunoreactive factors eliminated from serum samples by hydrophobic silica-gel extraction and enzyme immunoassay.
    Skogen WF; Rea MR; Valdes R
    Clin Chem; 1987 Mar; 33(3):401-4. PubMed ID: 3545537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin immunoassay with cross-reactivity of digoxin metabolites proportional to their biological activity.
    Miller JJ; Straub RW; Valdes R
    Clin Chem; 1994 Oct; 40(10):1898-903. PubMed ID: 7923769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of human serum with sulfosalicylic acid structurally alters digoxin and endogenous digoxin-like immunoreactive factor.
    Qazzaz HM; Goudy S; Miller JJ; Valdes R
    Ther Drug Monit; 1995 Feb; 17(1):53-9. PubMed ID: 7725377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparability of a new turbidimetric digoxin test with other immunochemical tests and with HPLC--a multicenter evaluation.
    Scholer A; Boecker J; Engelmayer U; Feldmann K; Hannak D; Kattermann R; Oellerich M; Raith H; Schlebusch H; Wieland H; Willems D; Jarausch J; Domke I
    Clin Chem; 1997 Jan; 43(1):92-9. PubMed ID: 8990228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. False-positive serum digoxin concentrations determined by three digoxin assays in patients with liver disease.
    Frisolone J; Sylvia LM; Gelwan J; Pal S; Pellechia C
    Clin Pharm; 1988 Jun; 7(6):444-9. PubMed ID: 3402179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and comparison of the TDxII, Stratus, and OPUS digoxin assays.
    Dodds HM; Norris RL; Johnson AG; Pond SM
    Ther Drug Monit; 1995 Feb; 17(1):68-74. PubMed ID: 7725380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.